Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIBAVIRIN vs RIFAMPIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RIBAVIRIN vs RIFAMPIN: Safety Overview

Metric RIBAVIRIN RIFAMPIN
Total FAERS Reports 43,397 13,347
Deaths Reported 2,494 1,439
Death Rate 5.7% 10.8%
Hospitalizations 8,495 5,764
Average Patient Age 55.7 yrs 51.7 yrs
% Female Patients 44.3% 47.8%
FDA Approval Date Apr 18, 2008 Approved Prior to Jan 1, 1982
Manufacturer Aurobindo Pharma Limited Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Discontinued